| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Climb Bio Inc's insiders have reduced their positions by a net 100,000 shares worth roughly $1.4M.
Classified under Biotechnology (Health Care sector), CLYM's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 468.0K | $6.40M | - | |
| CEO | 87.7K | $1.16M | - | |
| 10% | 70.0K | $242.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Thomas Stephen Basil | Director | Sell10b5-1 | 100,000 | $13.67 | $1,366,820.00 | -17.6% | - | - | |
| Jun 29, 2026 | Brennan Aoife58 | President and CEO | Sale+OE10b5-1 | 30,902 | $13.17 | $406,979.34 | -26.0% | -12.1% | - | |
| Feb 26, 2026 | Thomas Stephen Basil | Director | Sell10b5-1 | 50,000 | $7.01 | $350,252.84 | -24.4% | +61.8% | - | |
| Feb 13, 2026 | Thomas Stephen Basil | Director | Sell10b5-1 | 100,000 | $5.29 | $529,129.00 | -32.8% | +99.8% | - | |
| Jan 5, 2026 | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 7,111 | $3.50 | $24,888.50 | +0.2% | +90.4% | - | |
| Dec 12, 2025 | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 314,561 | $2.40 | $754,737.14 | +10.2% | +142.0% | - | |
| Jun 30, 2025 | Brennan Aoife58 | President and CEO | Sale+OE10b5-1 | 20,618 | $1.22 | $25,153.96 | -30.0% | +60.5% | +951.6% | |
| Jun 20, 2025 | Pimblett Emily49 | SVP, Finance &CAO | Sale+OE10b5-1 | 1,242 | $1.24 | $1,540.08 | -6.2% | +85.1% | +906.6% | |
| Mar 20, 2025 | Pimblett Emily49 | SVP, Finance &CAO | Sale+OE10b5-1 | 1,199 | $1.31 | $1,570.69 | -7.3% | -3.9% | +377.3% | |
| Dec 19, 2024 | Pimblett Emily49 | Chief Accounting Officer | Sale+OE10b5-1 | 1,235 | $2.02 | $2,494.70 | -9.8% | -30.8% | +119.5% |